Showing results (41-50 of 174) with videos related to

Sort By:
Pageof 18
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 19, 2019
Comparison between Upfront Transplantation and different Pretransplant Cytoreductive Treatment Approaches in Patients with High-Risk Myelodysplastic Syndrome and Secondary Acute Myelogenous LeukemiaThomas Schroeder, Nadija Wegener, Michael Lauseker, et al.
Annals of Hematology|January 10, 2025
Outcomes in patients with acute myeloid leukemia older than 70 years within the last 30 years, a single center experienceFelicitas Schulz, Claudia Roggenbuck, Andrea Kündgen, et al.
Blood Cancer Journal|November 14, 2019
Prognostic impact of peripheral blood WT1-mRNA expression in patients with MDSChristina Rautenberg, Ulrich Germing, Sabrina Pechtel, et al.
Cancers|May 14, 2022
Opportunities for Participation in Randomized Controlled Trials for Patients with Multiple Myeloma: Trial Access Depends on Restrictive Eligibility Criteria and Patient ExpectationsAmelie Boquoi, Veronika Rings, Annemarie Mohring, et al.
European Journal of Haematology|December 23, 2018
Interaction of increasing ICU survival and admittance policies in patients with hematologic neoplasms: A single center experience with 304 patientsMustafa Kondakci, Marc C Reinbach, Ulrich Germing, et al.
British Journal of Haematology|September 19, 2006
Exisulind induces apoptosis in advanced myelodysplastic syndrome (MDS) and acute myeloid leukaemia/MDSAkos Czibere, Wolf C Prall, Luiz F Zerbini, et al.
Scientific Reports|July 4, 2023
Allogeneic hematopoietic stem cell transplantation and pre-transplant strategies in patients with NPM1-mutated acute myeloid leukemia: a single center experiencePaul Jäger, Christina Rautenberg, Jennifer Kaivers, et al.
European Journal of Haematology|November 29, 2016
Sorafenib and azacitidine as salvage therapy for relapse of FLT3-ITD mutated AML after allo-SCTChristina Rautenberg, Kathrin Nachtkamp, Ariane Dienst, et al.
Blood|October 5, 2006
Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosisNicolaus Kröger, Anita Badbaran, Ernst Holler, et al.
Annals of Hematology|March 30, 2019
Relapse patterns and treatment strategies in patients receiving allogeneic hematopoietic stem cell transplantation for myeloid malignanciesEsther Schuler, Sarah Boughoufala, Christina Rautenberg, et al.
Pageof 18